NASDAQ$PGNY
Progyny Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Progyny's Q1 2024 financial results reflected revenue growth driven by increased clients and covered lives, but were impacted by unfavorable treatment mix shift and national conversations regarding fertility treatments. The company also returned value to shareholders through share repurchases.
Progyny's Q1 2024 revenue increased by 7.6% to $278.1 million, driven by growth in clients and covered lives. Net income was $16.9 million, or $0.17 per diluted share. The company repurchased 723,577 shares for $26.4 million during the quarter.
- Revenue increased by 7.6% year-over-year to $278.1 million.
- Net income was $16.9 million, or $0.17 per diluted share.
- Adjusted EBITDA increased by 8% year-over-year to $50.3 million.
- The company had 451 clients as of March 31, 2024, compared to 379 clients as of March 31, 2023.
Headline financials
Revenue & EPS history
Progyny · Revenue · Quarterly
$278M
Revenue by segment
Progyny · $281M total across 2 segments · Q3 2023
- Fertility Benefit Services$175M+35.4%62.3%
- Pharmacy Benefit Services$106M+39.0%37.7%
Forward guidance
The Company is providing the following financial guidance for the full year ending December 31, 2024 and the three-month period ending June 30, 2024:
Tailwinds
- Revenue is projected to be $300.0 million to $310.0 million, reflecting growth of 7% to 11%
- Net income is projected to be $15.7 million to $17.8 million, or $0.16 to $0.18 per diluted share
- Adjusted EBITDA is projected to be $52.0 million to $55.0 million
- Adjusted earnings per diluted share is projected to be $0.39 to $0.41
- Revenue is now projected to be $1,230 million to $1,270 million, reflecting growth of 13% to 17%
Headwinds
- Net income is projected to be $68.4 million to $75.4 million, or $0.68 to $0.75 per diluted share
- Adjusted EBITDA is projected to be $216.0 million to $226.0 million
- Adjusted earnings per diluted share is projected to be $1.61 to $1.68
- Utilization is now slightly lower than the record levels we saw in 2023
- Guidance has always been based on the utilization we are currently seeing, which informed our previous view of 2024
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-1.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
-0.2%
Avg return
30 days after
38%
11 / 29 earnings
Positive
+26.4%
Q2 2022
Best reaction
-20.5%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +25.4% | +38.2% | |
| Q4 2025 | -20.5% | -20.0% | -22.4% | |
| Q3 2025 | +24.3% | +33.6% | +33.4% | |
| Q1 2025 | -9.7% | -6.5% | -7.2% | |
| Q4 2024 | -1.5% | -5.2% | -4.3% | |
| Q3 2024 | -18.5% | -19.3% | -12.9% | |
| Q2 2024 | -17.7% | -14.7% | -6.4% | |
| Q1 2024 | -14.4% | -14.6% | -14.2% | |
| Q4 2023 | -13.1% | -9.7% | -4.3% | |
| Q3 2023 | -4.3% | -2.1% | +17.8% | |
| Q2 2023 | +4.9% | -2.8% | -8.6% | |
| Q1 2023 | +9.3% | +5.9% | +16.8% | |
| Q4 2022 | +22.9% | +18.4% | +7.7% | |
| Q3 2022 | -2.6% | +2.0% | -13.8% | |
| Q2 2022 | +26.4% | +25.5% | +15.4% | |
| Q1 2022 | -7.1% | -15.6% | -23.1% | |
| Q4 2021 | +11.5% | +13.0% | +31.6% | |
| Q3 2021 | +2.5% | +5.8% | -22.2% | |
| Q2 2021 | -12.8% | -17.1% | +4.3% | |
| Q1 2021 | -3.2% | -8.7% | +18.4% | |
| Q4 2020 | -15.5% | -14.9% | -14.4% | |
| Q3 2020 | -0.3% | +7.0% | +38.7% | |
| Q2 2020 | +0.4% | +8.4% | -0.9% | |
| Q1 2019 | -2.4% | +4.8% | -13.7% | |
| Q1 2020 | +21.8% | +18.8% | +2.1% | |
| Q4 2017 | -3.7% | -6.3% | -8.3% | |
| Q4 2019 | -12.2% | -15.5% | -39.0% | |
| Q4 2018 | -0.2% | -5.0% | -7.0% | |
| Q3 2019 | +0.5% | +0.3% | -6.5% | |
| Q2 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro